(c) 2024 PillSync.com

risperidone tablet film coated

1 INDICATIONS AND USAGE Risperidone tablets are an atypical antipsychotic indicated for: • Treatment of schizophrenia ( 1.1 ) • As monotherapy or adjunctive therapy with lithium or valproate, for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder ( 1.2 ) • Treatment of irritability associated with autistic disorder ( 1.3 ) 1.1 schizophrenia Risperidone tablets are indicated for the treatment of schizophrenia. Efficacy was established in 4 short-term trials in adults, 2 short-term trials in adolescents (ages 13 to 17 years), and one long-term maintenance trial in adults [see Clinical Studies (14.1) ]. 1.2 Bipolar Mania Monotherapy Risperidone tablets are indicated for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder. Efficacy was established in 2 short-term trials in adults and one short-term trial in children and adolescents (ages 10 to 17 years) [see Clinical Studies (14.2) ]. Adjunctive Therapy Risperidone tablets adjunctive therapy with lithium or valproate are indicated for the treatment of acute manic or mixed episodes associated with Bipolar I Disorder. Efficacy was established in one short-term trial in adults [see Clinical Studies (14.3) ]. 1.3 Irritability Associated with Autistic Disorder Risperidone tablets are indicated for the treatment of irritability associated with autistic disorder, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods. Efficacy was established in 3 short-term trials in children and adolescents (ages 5 to 17 years) [see Clinical Studies (14.4) ].

mylan pharmaceuticals inc.


6 years ago ROUND WHITE M R13 risperidone tablet film coated

ROUND WHITE M R13

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Risperidone Tablets, USP are available containing 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg or 4 mg of risperidone, USP. The 0.25 mg tablets are white, film-coated, round, unscored tablets debossed with M on one side of the tablet and R on the other side. They are available as follows: NDC 0378-3502-91 bottles of 60 tablets NDC 0378-3502-05 bottles of 500 tablets The 0.5 mg tablets are beige, film-coated, round, unscored tablets debossed with M on one side of the tablet and R5 on the other side. They are available as follows: NDC 0378-3505-91 bottles of 60 tablets NDC 0378-3505-05 bottles of 500 tablets The 1 mg tablets are white, film-coated, round, unscored tablets debossed with M on one side of the tablet and R11 on the other side. They are available as follows: NDC 0378-3511-91 bottles of 60 tablets NDC 0378-3511-05 bottles of 500 tablets The 2 mg tablets are beige, film-coated, round, unscored tablets debossed with M on one side of the tablet and R12 on the other side. They are available as follows: NDC 0378-3512-91 bottles of 60 tablets NDC 0378-3512-05 bottles of 500 tablets The 3 mg tablets are white, film-coated, round, unscored tablets debossed with M on one side of the tablet and R13 on the other side. They are available as follows: NDC 0378-3513-91 bottles of 60 tablets NDC 0378-3513-05 bottles of 500 tablets The 4 mg tablets are beige, film-coated, round, unscored tablets debossed with M on one side of the tablet and R14 on the other side. They are available as follows: NDC 0378-3514-91 bottles of 60 tablets 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Protect from light and moisture. Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Keep out of reach of children.


More pills like ROUND M R13

Related Pills

risperidone tablet film coated

mylan pharmaceuticals inc.

risperidone tablet film coated

mylan pharmaceuticals inc.

Risperidone Risperidone 3 MG Oral Tablet

Mylan Pharmaceuticals Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site